333 related articles for article (PubMed ID: 25895966)
41. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
[TBL] [Abstract][Full Text] [Related]
42. Twin-Arginine Translocation System Is Involved in Citrobacter rodentium Fitness in the Intestinal Tract.
Otake T; Fujimoto M; Hoshino Y; Ishihara T; Haneda T; Okada N; Miki T
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31818958
[TBL] [Abstract][Full Text] [Related]
43. The Probiotic Lactobacillus Prevents Citrobacter rodentium-Induced Murine Colitis in a TLR2-Dependent Manner.
Ryu SH; Park JH; Choi SY; Jeon HY; Park JI; Kim JY; Ham SH; Choi YK
J Microbiol Biotechnol; 2016 Jul; 26(7):1333-40. PubMed ID: 27056471
[TBL] [Abstract][Full Text] [Related]
44. Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo.
Klapproth JM; Sasaki M; Sherman M; Babbin B; Donnenberg MS; Fernandes PJ; Scaletsky IC; Kalman D; Nusrat A; Williams IR
Infect Immun; 2005 Mar; 73(3):1441-51. PubMed ID: 15731042
[TBL] [Abstract][Full Text] [Related]
45. Role of RpoS in the virulence of Citrobacter rodentium.
Dong T; Coombes BK; Schellhorn HE
Infect Immun; 2009 Jan; 77(1):501-7. PubMed ID: 18981255
[TBL] [Abstract][Full Text] [Related]
46. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium.
Kelly M; Hart E; Mundy R; Marchès O; Wiles S; Badea L; Luck S; Tauschek M; Frankel G; Robins-Browne RM; Hartland EL
Infect Immun; 2006 Apr; 74(4):2328-37. PubMed ID: 16552063
[TBL] [Abstract][Full Text] [Related]
47. RegA, an AraC-like protein, is a global transcriptional regulator that controls virulence gene expression in Citrobacter rodentium.
Hart E; Yang J; Tauschek M; Kelly M; Wakefield MJ; Frankel G; Hartland EL; Robins-Browne RM
Infect Immun; 2008 Nov; 76(11):5247-56. PubMed ID: 18765720
[TBL] [Abstract][Full Text] [Related]
48. Autophagy in the intestinal epithelium regulates Citrobacter rodentium infection.
Inoue J; Nishiumi S; Fujishima Y; Masuda A; Shiomi H; Yamamoto K; Nishida M; Azuma T; Yoshida M
Arch Biochem Biophys; 2012 May; 521(1-2):95-101. PubMed ID: 22475450
[TBL] [Abstract][Full Text] [Related]
49. Identification of a novel type IV pilus gene cluster required for gastrointestinal colonization of Citrobacter rodentium.
Mundy R; Pickard D; Wilson RK; Simmons CP; Dougan G; Frankel G
Mol Microbiol; 2003 May; 48(3):795-809. PubMed ID: 12694622
[TBL] [Abstract][Full Text] [Related]
50. Specialized Proresolving Mediators Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Reinfection.
Diaz LA; Altman NH; Khan WN; Serhan CN; Adkins B
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28694292
[TBL] [Abstract][Full Text] [Related]
51. Linking Pathogen Virulence, Host Immunity and The Microbiota at the Intestinal Barrier.
Nunez G
Keio J Med; 2017; 66(1):14. PubMed ID: 28356548
[TBL] [Abstract][Full Text] [Related]
52. Plasmacytoid Dendritic Cells Provide Protection Against Bacterial-Induced Colitis.
Rahman T; Brown AS; Hartland EL; van Driel IR; Fung KY
Front Immunol; 2019; 10():608. PubMed ID: 31024525
[TBL] [Abstract][Full Text] [Related]
53. Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli.
Henderson IR; Czeczulin J; Eslava C; Noriega F; Nataro JP
Infect Immun; 1999 Nov; 67(11):5587-96. PubMed ID: 10531204
[TBL] [Abstract][Full Text] [Related]
54. Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.
Silberger DJ; Zindl CL; Weaver CT
Mucosal Immunol; 2017 Sep; 10(5):1108-1117. PubMed ID: 28612839
[TBL] [Abstract][Full Text] [Related]
55. Utility of the Citrobacter rodentium infection model in laboratory mice.
Borenshtein D; McBee ME; Schauer DB
Curr Opin Gastroenterol; 2008 Jan; 24(1):32-7. PubMed ID: 18043230
[TBL] [Abstract][Full Text] [Related]
56. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis.
Wlodarska M; Willing B; Keeney KM; Menendez A; Bergstrom KS; Gill N; Russell SL; Vallance BA; Finlay BB
Infect Immun; 2011 Apr; 79(4):1536-45. PubMed ID: 21321077
[TBL] [Abstract][Full Text] [Related]
57. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota.
Kamada N; Kim YG; Sham HP; Vallance BA; Puente JL; Martens EC; Núñez G
Science; 2012 Jun; 336(6086):1325-9. PubMed ID: 22582016
[TBL] [Abstract][Full Text] [Related]
58. The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis.
Spahn TW; Maaser C; Eckmann L; Heidemann J; Lügering A; Newberry R; Domschke W; Herbst H; Kucharzik T
Gastroenterology; 2004 Nov; 127(5):1463-73. PubMed ID: 15521015
[TBL] [Abstract][Full Text] [Related]
59. Tight junctional disruption and apoptosis in an in vitro model of Citrobacter rodentium infection.
Flynn AN; Buret AG
Microb Pathog; 2008 Aug; 45(2):98-104. PubMed ID: 18504087
[TBL] [Abstract][Full Text] [Related]
60. STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis.
Backert I; Koralov SB; Wirtz S; Kitowski V; Billmeier U; Martini E; Hofmann K; Hildner K; Wittkopf N; Brecht K; Waldner M; Rajewsky K; Neurath MF; Becker C; Neufert C
J Immunol; 2014 Oct; 193(7):3779-91. PubMed ID: 25187663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
